Eric Winer, MD
Eric Winer, MD, Director of the Breast Oncology Program at Dana-Farber Cancer Institute was recognized earlier this month with The Jill Rose Award from the Breast Cancer Research Foundation (BCRF). This honor is given annually to a researcher in recognition of pioneering research in their particular field.
Dr. Winer has devoted his professional career to the treatment of individuals with breast cancer and breast cancer research. He has designed and conducted clinical trials that have changed clinical practice or paved the way toward more personalized treatment of breast cancer. His clinical research has included multimodality studies to determine optimal drug doses and treatment durations, the best treatment sequence and the most effective drug combinations to treat early, locally advanced and metastatic breast cancers.
Dr. Winer has also championed the concept of “more is not necessarily better” when it comes to breast cancer treatments, reminding oncologists that both the benefits and risks of treatments must be assessed when considering treatment options. Some of his more recent work has demonstrated the benefits of treatment de-escalation—the approach of identifying patients who will do as well with less treatment.
Dr. Winer is a member of the BCRF Scientific Advisory Board. ■
